Security record · archived quarter
ANGO
AngioDynamics, Inc. · Healthcare · Medical - Instruments & Supplies
10Tracked holders
n/aΔ holders
5.27MShares held
$31.86MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 43.99K | $609,074 | n/a | −2 |
| Q2 2026 | 71 | +3 | 20.21M | $262.94M | +7 | −5 |
| Q1 2026 | 71 | -1 | 21.06M | $239.47M | +4 | −5 |
| Q4 2025 | 72 | 0 | 22.40M | $287.62M | +1 | −1 |
| Q3 2025 | 18 | 0 | 15.02M | $167.73M | n/a | n/a |
| Q2 2025 | 15 | -1 | 13.76M | $136.51M | n/a | −1 |
| Q1 2025 | 13 | +2 | 6.65M | $62.49M | +2 | n/a |
| Q4 2024 | 11 | 0 | 7.29M | $66.82M | n/a | n/a |
| Q3 2024 | 10 | 0 | 5.47M | $42.55M | n/a | n/a |
| Q2 2024 | 10 | n/a | 5.27M | $31.86M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 1.79M | n/a | $10.85M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 1.10M | n/a | $6.64M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 914.36K | n/a | $5.53M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Two Sigma Investments ✦ | 485.37K | n/a | $2.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 316.75K | n/a | $1.92M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | AQR Capital Management ✦ | 310.31K | n/a | $1.88M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 7 | Citadel Advisors ✦ | 157.65K | n/a | $953,789 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 89.28K | n/a | $540,000 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 67.46K | n/a | $408,115 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 34.35K | n/a | $208,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 145 holders, 38.52M shares, $430.26M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API